These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29305727)

  • 1. Using Population Based Hospitalization Data to Monitor Increases in Conditions Causing Morbidity Among Persons Who Inject Drugs.
    Collier MG; Doshani M; Asher A
    J Community Health; 2018 Jun; 43(3):598-603. PubMed ID: 29305727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
    Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
    BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.
    Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR
    JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies.
    Elbatarny M; Bahji A; Bisleri G; Hamilton A
    Gen Hosp Psychiatry; 2019; 57():44-49. PubMed ID: 30908961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious Complications of Injection Drug Use.
    Marks LR; Nolan NS; Liang SY; Durkin MJ; Weimer MB
    Med Clin North Am; 2022 Jan; 106(1):187-200. PubMed ID: 34823730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.
    Thakarar K; Rokas KE; Lucas FL; Powers S; Andrews E; DeMatteo C; Mooney D; Sorg MH; Valenti A; Cohen M
    PLoS One; 2019; 14(11):e0225460. PubMed ID: 31770395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study.
    Gray ME; Rogawski McQuade ET; Scheld WM; Dillingham RA
    BMC Infect Dis; 2018 Oct; 18(1):532. PubMed ID: 30355291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of infective endocarditis in persons who inject drugs.
    Shah M; Wong R; Ball L; Puka K; Tan C; Shojaei E; Koivu S; Silverman M
    Harm Reduct J; 2020 Jun; 17(1):35. PubMed ID: 32503573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misclassification Error-Adjusted Prevalence of Injection Drug Use Among Infective Endocarditis Hospitalizations in the United States: A Serial Cross-Sectional Analysis of the 2007-2016 National Inpatient Sample.
    McGrew KM; Garwe T; Jafarzadeh SR; Drevets DA; Zhao YD; Williams MB; Carabin H
    Am J Epidemiol; 2021 Apr; 190(4):588-599. PubMed ID: 32997130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018.
    Capizzi J; Leahy J; Wheelock H; Garcia J; Strnad L; Sikka M; Englander H; Thomas A; Korthuis PT; Menza TW
    PLoS One; 2020; 15(11):e0242165. PubMed ID: 33166363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.
    Wurcel AG; Anderson JE; Chui KK; Skinner S; Knox TA; Snydman DR; Stopka TJ
    Open Forum Infect Dis; 2016 Sep; 3(3):ofw157. PubMed ID: 27800528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Infective Endocarditis in Injection Drug Users.
    Rudasill SE; Sanaiha Y; Mardock AL; Khoury H; Xing H; Antonios JW; McKinnell JA; Benharash P
    J Am Coll Cardiol; 2019 Feb; 73(5):559-570. PubMed ID: 30732709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors.
    Ramadan MS; Bertolino L; Boccia F; Hamieh M; Peluso AM; Gallo R; Patauner F; De Santo LS; Carozza A; Zampino R; Durante-Mangoni E;
    Intern Emerg Med; 2024 Mar; 19(2):455-464. PubMed ID: 38129537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.
    Tan C; Shojaei E; Wiener J; Shah M; Koivu S; Silverman M
    JAMA Netw Open; 2020 Aug; 3(8):e2012974. PubMed ID: 32785635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
    Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
    Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Infections Associated With Substance Use Disorders, Large Cohort of United States Hospitals, 2012-2017.
    McCarthy NL; Baggs J; See I; Reddy SC; Jernigan JA; Gokhale RH; Fiore AE
    Clin Infect Dis; 2020 Oct; 71(7):e37-e44. PubMed ID: 31907515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective Endocarditis Among Women Who Inject Drugs.
    Adams JA; Spence C; Shojaei E; Thandrasisla P; Gupta A; Choi YH; Skinner S; Silverman M
    JAMA Netw Open; 2024 Oct; 7(10):e2437861. PubMed ID: 39365578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Care for Persons Who Inject Drugs.
    Visconti AJ; Sell J; Greenblatt AD
    Am Fam Physician; 2019 Jan; 99(2):109-116. PubMed ID: 30633481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor.
    Morelli MK; Veve MP; Lorson W; Shorman MA
    Mycoses; 2021 Feb; 64(2):181-186. PubMed ID: 33073384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.